אודות פרק זה
In recent years, we have seen 3D printing put to an ever-expanding range of uses in the medical field. Products printed with manmade materials include implants, scaffolds, anatomical models and personalized devices and masks. In addition, the area of bioprinting has begun to expand, with researchers now printing live cells in order to encourage regeneration and create tissues and organs. Now, the two areas have become entwined: Michael McAlpine and his research team are developing 3D printers that are capable of printing functional materials and devices that interweave both biological and electronic materials. These new printers could impact regenerative medicine, smart prosthetics and human-machine interfaces by enabling the creation of products with customized geometries, properties and functionalities.
In this interview, Michael McAlpine, Benjamin Mayhugh Associate Professor of Mechanical Engineering at the University of Minnesota (MN, USA), discusses his work and the increasing range of uses for 3D printing in the medical field - scroll down for the video and a summary of the questions and their timepoints.
In this interview, Michael McAlpine, Benjamin Mayhugh Associate Professor of Mechanical Engineering at the University of Minnesota (MN, USA), discusses his work and the increasing range of uses for 3D printing in the medical field - scroll down for the video and a summary of the questions and their timepoints.
אנגלית
ארצות הברית
תעתיק 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
פרקים אחרים בפודקאסט הזה
First-line management of unresectable hepatocellular carcinoma: clinical perspectives from the CheckMate 9DW study by Taylor & Francis Group
Over the past two decades, HER2-positive breast cancer has undergone a dramatic transformation in oncology. In this interview, Cristina Saura (Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Spain) reflects on witnessing this evolution firsthand, from the introduction of…
The patient authors with over 48 years of combined real-world experience with chronic myeloid leukemia, and a healthcare professional, use their own personal experiences to describe the factors that may affect the patient–doctor relationship, patient care and outcomes. The authors believe that thi…
In this interview, Imogen Locke (The Royal Marsden NHS Foundation Trust, UK) discusses the evolving role of stereotactic ablative radiotherapy (SABR) in oligometastatic and oligoprogressive breast cancer.
Locke explains the distinction between these two clinical scenarios, how timing and patient …
Christopher Lieu, co-director of gastrointestinal medical oncology and the associate director for clinical research at the University of Colorado Cancer Center (CO, USA) discusses the importance of biomarker testing in metastatic colorectal cancer to inform personalized patient care.
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Taylor & Francis Group, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
